Literature DB >> 8490026

Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells.

C A Stein1, J L Tonkinson, L M Zhang, L Yakubov, J Gervasoni, R Taub, S A Rotenberg.   

Abstract

We have examined the cellular association and internalization of phosphodiester (PO) oligodeoxynucleotides (oligos) with HL60 cells. At 4 degrees C, a 15-mer PO homopolymer of thymidine (FOdT15) exhibits apparent saturation binding (Km = 22 +/- 1 nM) that is competitive with the binding of phosphorothioate (PS) oligos. The value of Kc for SdC28, a PS 28-mer homopolymer of cytidine, is 5 +/- 2 nM. SdC28 was used to strip cell surface fluorescence: Internalized fluorescence accumulated in a (concentration)(time)-dependent fashion, consistent with a pinocytotic mechanism. PS, and to a lesser extent, PO oligos inhibited the rate of internalization of fluorescent albumin, also a marker of pinocytosis. This was correlated with direct in vitro inhibition of protein kinase C (PKC) beta 1 by the PS and PO oligos. Furthermore, other PKC inhibitors (H7, staurosporine, DMSO, PKC pseudosubstrate polypeptide) also inhibited intracellular accumulation of pinocytosed materials, perhaps by stimulating the exocytosis rate. In HL60 cells, the pinocytotic internalization of charged oligos appears to be dependent on intact PKC kinase activity, which is inhibited in vitro by PS and PO oligos.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8490026     DOI: 10.1021/bi00069a022

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  31 in total

1.  Nuclear transport of oligonucleotides in HepG2-cells mediated by protamine sulfate and negatively charged liposomes.

Authors:  C Welz; W Neuhuber; H Schreier; M Metzler; R Repp; W Rascher; A Fahr
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  The experimental use of antisense oligonucleotides: a guide for the perplexed.

Authors:  C A Stein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  Post-transcriptional silencing of Notch2 mRNA in chronic lymphocytic [corrected] leukemic cells of B-CLL patients.

Authors:  Kaneez Fatima; Rehan Zafar Paracha; Ishtiaq Qadri
Journal:  Mol Biol Rep       Date:  2011-12-10       Impact factor: 2.316

4.  A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain.

Authors:  Mahesh M Thakkar; Stuart Winston; Robert W McCarley
Journal:  J Neurosci       Date:  2003-05-15       Impact factor: 6.167

5.  Evaluation of adjuvants that enhance the effectiveness of antisense oligodeoxynucleotides.

Authors:  J A Hughes; A I Aronsohn; A V Avrutskaya; R L Juliano
Journal:  Pharm Res       Date:  1996-03       Impact factor: 4.200

6.  Radiolabeled oligonucleotides for antisense imaging.

Authors:  Arun K Iyer; Jiang He
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

Review 7.  Flow cytometry applications in pharmacodynamics and drug delivery.

Authors:  M Ramanathan
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

8.  5'-Cholesteryl-phosphorothioate oligodeoxynucleotides: potent inhibition of methotrexate transport and antagonism of methotrexate toxicity in cells containing the reduced-folate carrier.

Authors:  G B Henderson; C A Stein
Journal:  Nucleic Acids Res       Date:  1995-09-25       Impact factor: 16.971

9.  Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.

Authors:  C Beltinger; H U Saragovi; R M Smith; L LeSauteur; N Shah; L DeDionisio; L Christensen; A Raible; L Jarett; A M Gewirtz
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  Interactions of phosphodiester and phosphorothioate oligonucleotides with intestinal epithelial Caco-2 cells.

Authors:  G F Beck; W J Irwin; P L Nicklin; S Akhtar
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.